GRAYSPACE THERAPEUTICS Trademark

Trademark Overview

On Wednesday, April 15, 2020, a trademark application was filed for GRAYSPACE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the GRAYSPACE THERAPEUTICS trademark a serial number of 88873267. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Thursday, February 29, 2024. This trademark is owned by Med-Life Discoveries GP Inc.. The GRAYSPACE THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Plasmalogen-based therapeutic compounds for the treatment of Alzheimer's Disease, Parkinson's Disease and other neurological indications that have a plasmalogen deficiency
grayspace therapeutics

General Information

Serial Number88873267
Word MarkGRAYSPACE THERAPEUTICS
Filing DateWednesday, April 15, 2020
Status653 - SUSPENSION LETTER - MAILED
Status DateThursday, February 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPlasmalogen-based therapeutic compounds for the treatment of Alzheimer's Disease, Parkinson's Disease and other neurological indications that have a plasmalogen deficiency
Pseudo MarkGRAY SPACE THERAPEUTICS
Disclaimer with Predetermined Text"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 23, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMed-Life Discoveries GP Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSaskatoon, SK S7N2X8
CA

Trademark Events

Event DateEvent Description
Thursday, February 29, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, February 29, 2024LETTER OF SUSPENSION E-MAILED
Thursday, February 29, 2024SUSPENSION LETTER WRITTEN
Thursday, February 29, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 29, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 28, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, February 22, 2024NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, February 22, 2024INQUIRY TO SUSPENSION E-MAILED
Thursday, February 22, 2024SUSPENSION INQUIRY WRITTEN
Friday, February 16, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, August 15, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, August 15, 2023LETTER OF SUSPENSION E-MAILED
Tuesday, August 15, 2023SUSPENSION LETTER WRITTEN
Monday, August 14, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 14, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 14, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, July 19, 2023NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, July 19, 2023INQUIRY TO SUSPENSION E-MAILED
Wednesday, July 19, 2023SUSPENSION INQUIRY WRITTEN
Tuesday, July 18, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, December 15, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, December 15, 2022LETTER OF SUSPENSION E-MAILED
Thursday, December 15, 2022SUSPENSION LETTER WRITTEN
Thursday, December 15, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 15, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 13, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, November 23, 2022NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, November 23, 2022INQUIRY TO SUSPENSION E-MAILED
Wednesday, November 23, 2022SUSPENSION INQUIRY WRITTEN
Friday, November 18, 2022SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, April 7, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, April 7, 2022LETTER OF SUSPENSION E-MAILED
Thursday, April 7, 2022SUSPENSION LETTER WRITTEN
Tuesday, April 5, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 5, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 1, 2022ASSIGNED TO LIE
Wednesday, March 30, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, October 5, 2021NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, October 5, 2021INQUIRY TO SUSPENSION E-MAILED
Tuesday, October 5, 2021SUSPENSION INQUIRY WRITTEN
Monday, October 4, 2021SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Friday, March 19, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, March 19, 2021LETTER OF SUSPENSION E-MAILED
Friday, March 19, 2021SUSPENSION LETTER WRITTEN
Thursday, March 18, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 18, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 18, 2021ASSIGNED TO LIE
Tuesday, December 15, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 16, 2020WITHDRAWAL OF ATTORNEY GRANTED
Wednesday, September 16, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Tuesday, July 7, 2020NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Tuesday, July 7, 2020EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Tuesday, July 7, 2020COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Tuesday, July 7, 2020EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Monday, July 6, 2020ASSIGNED TO EXAMINER
Thursday, April 23, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, April 18, 2020NEW APPLICATION ENTERED

Related Keywords

therapeutics grayspace plasmalogen disease other neurological deficiency indications parkinson alzheimer based therapeutic